BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

9:41 PM
 | 
Jun 18, 2007
 |  BC Extra  |  Company News

CMS confirms Xopenex payment cut

The Centers for Medicare & Medicaid Services confirmed its plan to reduce reimbursement for asthma drug Xopenex levalbuterol from Sepracor (SEPR) by paying for it at the same rate as generic albuterol. The new policy, which goes into effect July 1, eliminates the reimbursement code for Xopenex under Medicare Part B and forces the product into a new code that includes Xopenex and...

Read the full 304 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >